Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on rare diseases, multiple sclerosis, immunology, and oncology. They help people with debilitating and complex conditions that are often difficult to diagnose and treat. They are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world. Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, they also established ourselves as a leader in the field of multiple sclerosis. In 2016, their focus expanded to include Sanofi’s programs in oncology and immunology. Their approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Founded as Genzyme in Boston in 1981, they rapidly grew to become one of the world’s leading biotechnology companies, recognized for their pioneering development of treatments for rare genetic disorders and their innovative contributions to medical science and biomanufacturing.

Ultra Ink operates in the healthcare industry. Founded in 2011, the company is headquartered in Atlanta, Georgia, United States.

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

USV Private Limited is a 55 year old leading healthcare company which began as a joint venture with USV&P Inc. USA, a subsidiary of Revlon. Their product offering today includes Active Pharmaceutical Ingredients (APIs), Fixed Dosages Formulations (FDF), Peptides, Biosimilars and Injectables. These are manufactured in our cGMP compliant plants located in India.

Shandong Xinhua Pharmaceutical Co., Ltd. engages in the development, production and sales of pharmaceutical and synthetic chemical products. It operates the business through the following segments: Bulk Pharmaceuticals, Preparations, Chemical and Other Products. The firm's products include analgin, caffeine, amidopyrine, ibuprofen, theophylline, aspirin, hydrocortisone and pipemidic acid. The company also sells pharmaceutical raw materials, preprations, antibiotic preparations, herbal medicine, biological products, medical appliances, chinese medicines and beauty products. Shandong Xinhua Pharmaceutical was founded in 1943 and is headquartered in Zibo, China.

Nitto Boseki Co., Ltd. engages in the manufacture processing and sale of textile products and materials. It operates through the following business segments: Textiles, Raw Fiber Materials, Functional Materials, Equipment Materials, Life Science, and Others. The Textiles segment handles the manufacture and sale of core spun yarn, stretch products, interlining products and others. The Raw Fiber Materials segment manufactures and sells fiberglass raw fiber products like yarn, roving, and chopped strands. The Functional Materials segment covers the manufacture and sales of glass fiber functional products. The Equipment Materials segment includes glass fiber products for industrial materials, and manufactures and sells glass wool products (for heat insulating materials). The Life Science segment manufactures and sells in-vitro diagnostic drugs, specialty chemicals products, and soft drinks. The Others segment deals with industrial machinery and equipment related business and service business. The company was founded on April 18, 1918 and is headquartered in Tokyo, Japan.

Suzhou Yudeshui Electric Technology Co., Ltd., established on 2014-09-24, Business scope includes research and development,Sales:Electrical Equipment,Wujinjiaodian,electronic product,scale,load cell,Telecommunications equipment,Wire and Cable,Electrical Equipment,Instrumentation,scanner,photo frame,snapshot device,switch electrical appliances,small power generation equipment,wind power equipment,Photoelectric equipment,automation equipment;Sales:household appliances,electrical tools,office equipment,cosmetic.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Wanxiang 123 Co., Ltd. engages in the design and technology upgrade of lithium-ion batteries and lithium-ion battery systems assembled by power batteries; manufacturing of lithium-ion power batteries; as well as the sale of its products. The company was founded on July 13, 2011 and is headquartered in Hangzhou, China.

Qingdao Senlida Packaging Co., Ltd., established on 2006-09-25, Business scope includes licensed projects:Packaging and decoration printing;Production of plastic packaging containers and tool products for food.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Manufacturing of plastic products;Mechanical Parts,Parts sales;Non-residential real estate leases;Sales of plastic packaging containers and tool products for food;Sales of plastic products;Mechanical Parts,Parts processing;Manufacturing of medical packaging materials.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Hubei Huashitong Biomedical Technology Co., Ltd., established on 2008-01-31, The business scope includes pharmaceutical raw materials,biological fermentation,Production and sales of pharmaceutical intermediates;chemical reagent,Chemical Products(3-Aminopropene500Ton/year,diallylamine500Ton/year,triallylamine50Ton/year,Methyl fluoroacetate500Ton/year,potassium chloride(by-product)460Ton/year)Development,to develop,Technical Services and Consulting(The country has special regulations to operate with a license);Import and export,Technology Import and Export(Import and export of goods and technology that are not restricted or prohibited by the state).(Involved in licensing projects,It should be operated after obtaining the permission of the relevant department)

Guangdong Huankai Biotechnology Co., Ltd., established on 2018-10-25, Business scope includes biotechnology services,technology development,Technology Promotion;Production of edible fungi,research and development,Sales;Edible mushroom technology transfer;Deep processing of edible mushroom products;Health food research and development,Production,Sales;food production;food sales;beverage production;detergent,disinfectant,lubricant,Physical and chemical rapid detection products,Sales of Medical Devices;detergent,disinfectant,Equipment and raw and auxiliary materials required for the production and sales of lubricants;Hazardous Chemicals Management(The above business items are in<Hazardous Chemical Business License>(Yue Shao Wu Wei(Second)Character[2022]001)The number and the characters of Cantonese and Shaowei Huajing[2022]000004The license scope and validity period of the license number).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Founder Pharmaceutical Research Institute Co., Ltd., established on 2008-09-04, Business scope includes research and development of pharmaceutical products(Except for pharmaceutical production),technology transfer,Technical Services,technical consulting;Investment;Technology Import and Export,Import and export.(After receiving this license,Need to report to the District Chamber of Commerce).(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Chengda Pharmaceutical is a technology company that engages in research and development, production, and sales of pharmaceutical intermediates, chemical raw materials, food additives, and feed additives. They provide CDMO services such as process development and optimization, quality research, customized production of key pharmaceutical intermediates, and more.

Guangdong Huankai Biotechnology Co., Ltd., established on 2014-10-29, The scope of business includes microbial products,Reagent,bacteria,Research on physical and chemical rapid detection products,to develop,Production,Sales,Technical service and technical consultation(The above does not include varieties prohibited and restricted by the state);Sales:microorganism,detergent,disinfectant,Equipment and raw and auxiliary materials required for lubricant research and production,chemical glassware,Electrical Equipment,medical instruments;Agricultural machinery and equipment,Research on environmental protection equipment and equipment,to develop,Production,Sales,Technical Consulting and Services;Research and development of laboratory instruments and equipment,production and sales;Health food production and sales(tablet,powder),research and development;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval);Real estate development and management;food business;licensed items:pharmaceutical production;Feed additive production;food production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:R&D and application of cell technology;Biochemical product technology research and development;Research and development of biopesticide technology;Research and development of technology for the harmless utilization of agricultural and forestry waste resources;glassware manufacturing;Manufacturing of plastic products;Production of labor protection products;Food Internet Sales(Only sell prepackaged food);Engineering and Technology Research and Experimental Development;housing lease;Non-residential real estate leases.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Hebei Xinerte Rubber & Plastic Sealing Co., Ltd., established on 2006-04-29, Business scope includes production,Sales of rubber products,plastic products,Rubber and plastic seals,hose,metal processing,mold making,Labor subcontracting,Technical Services,Import and export of goods and technology**(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

National Institute for Materials Science (物質・材料研究機構 Busshitsu-zairyō kenkyū kikō) is an Independent Administrative Institution and one of the largest scientific research centers in Japan.

Pushner (Suzhou) Industrial Technology Co., Ltd., established on 2017-03-02, Business scope includes research and development,Sales:industrial equipment,Adhesive products,water-based paint,cleaning supplies,Intelligent detection equipment and software,And provide relevant technical advice,After-sales service;Production,Sales:Electrical Equipment;Sales:Industrial Automation Equipment,Mechanical equipment and accessories;Sales,Install:rubber products,Wujinjiaodian;Fire Technology,Ecotechnology,Technology development in the field of network technology,technical consulting,technology transfer,Technical Services;Development of drones,Sales and technical service;Design of Industrial Automation and Measurement and Control System,Install,Commissioning and maintenance;Undertake geographic information system engineering;computer software development.Import and export;Technology Import and Export;Manufacture of graphite and carbon products;additive manufacturing;Electronic special material manufacturing;Manufacturing of plastic products;Metal surface treatment and heat treatment;Manufacturing of daily chemical products;Glass fiber and product manufacturing;Manufacture of special ceramic products;Manufacturing of thermal and acoustic insulation materials;Refractory production;Manufacturing of non-ferrous metal alloys;Manufacturing of special equipment(Manufacture of licensed professional equipment not included);paint sales(Free of Hazardous Chemicals);Specialty Chemicals Sales(Free of Hazardous Chemicals);Synthetic Materials Sales;Special Equipment Repair;Complete set of nuclear power equipment and engineering technology research and development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

LSI Medience Corp. engages in the clinical examination business. It also engages in the diagnostic agent and drug discovery support business. The company was founded on April 1, 2014 and is headquartered in Tokyo, Japan.